Lack of Association Between Dendritic Cell Nuclear Protein-1 Gene and Major Depressive Disorder in the Han Chinese Population.
Lack of association between dendritic cell nuclear protein-1 gene and major depressive disorder in the Han Chinese population.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 22;
Li H, Wang YJ, Hua L, Yang YT, Zhang M, Zhang D, Wang C,… Continue reading
Evaluation of Digoxin Concentration After Loading Dose in Patients With Renal Dysfunction.
Evaluation of digoxin concentration after loading dose in patients with renal dysfunction.
Can J Hosp Pharm. 2013 Mar; 66(2): 104-9
Pawlosky N, Macdonald E, Patel R, Kanji S
Loading dose recommendations for digoxin are based on the volume of… Continue reading
Development of Figurative Language Skills Following Central Nervous System-Directed Chemotherapy Delivered in Early Childhood.
Development of figurative language skills following central nervous system-directed chemotherapy delivered in early childhood.
Int J Speech Lang Pathol. 2013 Apr 23;
Dowling EK, Lewis FM, Murdoch BE
Central nervous system (CNS)-directed chemotherapy is delivered for the treatment of… Continue reading
Effects of Academic Service Learning in Drug Misuse and Addiction on Students’ Learning Preferences and Attitudes Toward Harm Reduction.
Effects of academic service learning in drug misuse and addiction on students’ learning preferences and attitudes toward harm reduction.
Am J Pharm Educ. 2013 Apr 12; 77(3): 63
Kabli N, Liu B, Seifert T, Arnot MI
Objective. To examine… Continue reading
Safety and Efficacy of Deferasirox in the Management of Transfusion-Dependent Patients With Myelodysplastic Syndrome and Aplastic Anaemia: A Perspective Review.
Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.
Ther Adv Hematol. 2013 Apr; 4(2): 93-102
Adams RL, Bird RJ
Deferasirox is an orally administered, once-daily iron chelator… Continue reading
Safety and Efficacy of Pralatrexate in the Treatment of Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.
Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Ther Adv Hematol. 2012 Aug; 3(4): 227-35
Marchi E, O’Connor OA
T-cell lymphomas (TCL) are a diverse and heterogeneous group of malignancies… Continue reading